3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
2
Completed
2
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Observational
2
Sponsor
Cancer Type
Plasma cell
1
Gynecologic
1
Conditions
Smoldering Multiple Myeloma
1
Ovarian Neoplasms
1
Neoplasms, Plasma Cell
1
Monoclonal Gammopathy of Undetermined Significance
1
Interventions
pembrolizumab
244
Nivolumab
140
Cisplatin
135
Cyclophosphamide
134
Paclitaxel
113
Carboplatin
108
Gemcitabine
98
Radiotherapy
83
Dexamethasone
83
Docetaxel
77
atezolizumab
68
Ipilimumab
68
Doxorubicin
62
Fluorouracil
60
Blood Specimen Collection
58
Bevacizumab
58
fludarabine
54
Rituximab
54
Etoposide
53
Oxaliplatin
52
Surveys and Questionnaires
49
Lenalidomide
49
Prednisone
47
Standard of Care
45
Magnetic Resonance Spectroscopy
45
Cetuximab
44
Capecitabine
44
lenvatinib
43
Radiosurgery
43
durvalumab
42
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
Urination
×
1 year
×
Clear all
NCT03951220
2025-08-19
LOOMIS
Oxford University Hospitals NHS Trust
Completed
67 enrolled
24 charts
NCT03831230
2025-08-08
OVAREX
Centre Francois Baclesse
Completed
250 enrolled